Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first501 to 520 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| MTHFR methylenetetrahydrofolate reductase | 4524 HGNC:7436 | 1 | 104 | 0 | 0 | 3,892 | 14,567 |
| CYP1A2 cytochrome P450 family 1 subfamily A member 2 | 1544 HGNC:2596 | 1 | 32 | 0 | 0 | 3,993 | 14,556 |
| CXCR3 C-X-C motif chemokine receptor 3 | 2833 HGNC:4540 | 1 | 207 | 0 | 0 | 7,710 | 14,523 |
| ENO1 enolase 1 | 2023 HGNC:3350 | 1 | 160 | 0 | 0 | 4,973 | 14,516 |
| TNFRSF11B TNF receptor superfamily member 11b | 4982 HGNC:11909 | 1 | 102 | 0 | 0 | 4,084 | 14,514 |
| SLC2A4 solute carrier family 2 member 4 | 6517 HGNC:11009 | 1 | 44 | 0 | 0 | 5,547 | 14,505 |
| ABO ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 28 HGNC:79 | 1 | 13 | 0 | 0 | 4,066 | 14,499 |
| IL2RB interleukin 2 receptor subunit beta | 3560 HGNC:6009 | 1 | 305 | 10 | 858 | 7,378 | 14,488 |
| TRIM21 tripartite motif containing 21 | 6737 HGNC:11312 | 1 | 76 | 0 | 0 | 3,380 | 14,443 |
| THBS1 thrombospondin 1 | 7057 HGNC:11785 | 1 | 163 | 0 | 0 | 7,265 | 14,429 |
| H2BC21 H2B clustered histone 21 | 8349 HGNC:4760 | 1 | 55 | 0 | 0 | 7,156 | 14,416 |
| SREBF1 sterol regulatory element binding transcription factor 1 | 6720 HGNC:11289 | 1 | 61 | 0 | 0 | 5,690 | 14,402 |
| LOC102724197 inactive glutathione hydrolase 2 | 102724197 | 0 | 0 | 0 | 0 | 2,251 | 14,382 |
| GAST gastrin | 2520 HGNC:4164 | 1 | 84 | 0 | 0 | 2,821 | 14,352 |
| BMP4 bone morphogenetic protein 4 | 652 HGNC:1071 | 1 | 284 | 0 | 0 | 8,065 | 14,198 |
| MT-TG mitochondrially encoded tRNA-Gly (GGN) | 4563 HGNC:7486 | 0 | 0 | 0 | 0 | 5,804 | 14,043 |
| FUT4 fucosyltransferase 4 | 2526 HGNC:4015 | 1 | 43 | 0 | 0 | 5,760 | 13,993 |
| MRAP melanocortin 2 receptor accessory protein | 56246 HGNC:1304 | 1 | 16 | 0 | 0 | 9,080 | 13,974 |
| CXADRP1 CXADR pseudogene 1 | 653108 HGNC:23770 | 0 | 0 | 0 | 0 | 4,689 | 13,961 |
| NPY neuropeptide Y | 4852 HGNC:7955 | 1 | 135 | 0 | 0 | 6,279 | 13,933 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=26
{
"data": {
"total": 193990,
"results": [
{
"id": "4524",
"title": "MTHFR: methylenetetrahydrofolate reductase",
"summary": "NCBI Gene 4524. 1 protein, 104 patents, 0 drugs, 0 trials, 3,892 NIH grants and 14,567 papers.",
"record": "/library/genes/4524",
"gene_id": 4524,
"symbol": "MTHFR",
"name": "methylenetetrahydrofolate reductase",
"hgnc_id": "HGNC:7436",
"counts": {
"proteins": 1,
"patents": 104,
"drugs": 0,
"trials": 0,
"grants": 3892,
"papers": 14567
}
},
{
"id": "1544",
"title": "CYP1A2: cytochrome P450 family 1 subfamily A member 2",
"summary": "NCBI Gene 1544. 1 protein, 32 patents, 0 drugs, 0 trials, 3,993 NIH grants and 14,556 papers.",
"record": "/library/genes/1544",
"gene_id": 1544,
"symbol": "CYP1A2",
"name": "cytochrome P450 family 1 subfamily A member 2",
"hgnc_id": "HGNC:2596",
"counts": {
"proteins": 1,
"patents": 32,
"drugs": 0,
"trials": 0,
"grants": 3993,
"papers": 14556
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=27",
"request_id": "vTY0uY4_sE_h-om2"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant